{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T16:01:27Z","timestamp":1790438487353,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018552","name":"Science and Technology Plan Project of Taizhou","doi-asserted-by":"publisher","award":["25ywb02"],"award-info":[{"award-number":["25ywb02"]}],"id":[{"id":"10.13039\/501100018552","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.intimp.2026.117305","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T18:49:14Z","timestamp":1787078954000},"page":"117305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Epigenetic inactivation of COL4A4 orchestrates JAK2\/STAT3-driven progression and microenvironment reprogramming in renal cell carcinoma"],"prefix":"10.1016","volume":"188","author":[{"given":"Hanxi","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiong","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanjing","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingmin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.intimp.2026.117305_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.intimp.2026.117305_bb0010","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.eururo.2018.08.036","article-title":"Epidemiology of renal cell carcinoma","volume":"75","author":"Capitanio","year":"2019","journal-title":"Eur. Urol."},{"key":"10.1016\/j.intimp.2026.117305_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2021.09.014","article-title":"KLF2 inhibits cancer cell migration and invasion by regulating ferroptosis through GPX4 in clear cell renal cell carcinoma","volume":"522","author":"Lu","year":"2021","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.intimp.2026.117305_bb0020","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41420-022-01151-w","article-title":"FTO promotes clear cell renal cell carcinoma progression via upregulation of PDK1 through an m(6)a dependent pathway","volume":"8","author":"Shen","year":"2022","journal-title":"Cell Death Discov."},{"issue":"1","key":"10.1016\/j.intimp.2026.117305_bb0025","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12967-023-03913-1","article-title":"ADAM12 promotes clear cell renal cell carcinoma progression and triggers EMT via EGFR\/ERK signaling pathway","volume":"21","author":"Xu","year":"2023","journal-title":"J. Transl. Med."},{"issue":"4","key":"10.1016\/j.intimp.2026.117305_bb0030","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s10555-014-9533-1","article-title":"Molecular aberrations, targeted therapy, and renal cell carcinoma: current state-of-the-art","volume":"33","author":"Randall","year":"2014","journal-title":"Cancer Metastasis Rev."},{"issue":"5","key":"10.1016\/j.intimp.2026.117305_bb0035","article-title":"Immunotherapy for metastatic renal cell carcinoma","volume":"5","author":"Unverzagt","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"issue":"4","key":"10.1016\/j.intimp.2026.117305_bb0040","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s40291-018-0337-9","article-title":"The role of DNA methylation in renal cell carcinoma","volume":"22","author":"Lasseigne","year":"2018","journal-title":"Mol. Diagn. Ther."},{"key":"10.1016\/j.intimp.2026.117305_bb0045","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4939-1804-1_1","article-title":"Cancer epigenetics: an introduction","volume":"1238","author":"Kanwal","year":"2015","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117305_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2022.166583","article-title":"Blood-based DNA methylation signatures in cancer: a systematic review","volume":"1869","author":"Li","year":"2023","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"issue":"21","key":"10.1016\/j.intimp.2026.117305_bb0055","doi-asserted-by":"crossref","first-page":"9700","DOI":"10.1073\/pnas.91.21.9700","article-title":"Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma","volume":"91","author":"Herman","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.intimp.2026.117305_bb0060","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12943-023-01871-2","article-title":"ELF5 drives angiogenesis suppression though stabilizing WDTC1 in renal cell carcinoma","volume":"22","author":"Li","year":"2023","journal-title":"Mol. Cancer"},{"issue":"7","key":"10.1016\/j.intimp.2026.117305_bb0065","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41585-018-0023-z","article-title":"Epigenetics in renal cell cancer: mechanisms and clinical applications","volume":"15","author":"Joosten","year":"2018","journal-title":"Nat. Rev. Urol."},{"issue":"11","key":"10.1016\/j.intimp.2026.117305_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20112657","article-title":"DNA-methylation-based detection of urological Cancer in urine: overview of biomarkers and considerations on biomarker design, source of DNA, and detection technologies","volume":"20","author":"Larsen","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.intimp.2026.117305_bb0075","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1586\/14737159.2015.1019477","article-title":"Epigenetic biomarkers in the blood of patients with urological malignancies","volume":"15","author":"Ellinger","year":"2015","journal-title":"Expert Rev. Mol. Diagn."},{"issue":"1","key":"10.1016\/j.intimp.2026.117305_bb0080","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/cncr.26254","article-title":"Serum cell-free DNA in renal cell carcinoma: a diagnostic and prognostic marker","volume":"118","author":"de Martino","year":"2012","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.intimp.2026.117305_bb0085","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/path.1396","article-title":"The basement membrane matrix in malignancy","volume":"200","author":"Engbring","year":"2003","journal-title":"J. Pathol."},{"issue":"2","key":"10.1016\/j.intimp.2026.117305_bb0090","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00795-013-0064-6","article-title":"Invasion and metastasis of renal cell carcinoma","volume":"47","author":"Mikami","year":"2014","journal-title":"Med. Mol. Morphol."},{"issue":"6","key":"10.1016\/j.intimp.2026.117305_bb0095","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1046\/j.1523-1755.1999.00785.x","article-title":"Renal basement membrane components","volume":"56","author":"Miner","year":"1999","journal-title":"Kidney Int."},{"issue":"11","key":"10.1016\/j.intimp.2026.117305_bb0100","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/s41581-025-00982-x","article-title":"Collagen IV in Gould syndrome and Alport syndrome","volume":"21","author":"Massoudi","year":"2025","journal-title":"Nat. Rev. Nephrol."},{"issue":"5","key":"10.1016\/j.intimp.2026.117305_bb0105","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/jemt.20564","article-title":"Mammalian collagen IV","volume":"71","author":"Khoshnoodi","year":"2008","journal-title":"Microsc. Res. Tech."},{"issue":"12","key":"10.1016\/j.intimp.2026.117305_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105459","article-title":"Collagen IV of basement membranes: II. Emergence of collagen IV(alpha345) enabled the assembly of a compact GBM as an ultrafilter in mammalian kidneys","volume":"299","author":"Pokidysheva","year":"2023","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.intimp.2026.117305_bb0115","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1053\/j.ajkd.2020.03.026","article-title":"Alport syndrome: achieving early diagnosis and treatment","volume":"77","author":"Kashtan","year":"2021","journal-title":"Am. J. Kidney Dis."},{"issue":"2","key":"10.1016\/j.intimp.2026.117305_bb0120","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1046\/j.1523-1755.2001.060002480.x","article-title":"COL4A4 mutation in thin basement membrane disease previously described in Alport syndrome","volume":"60","author":"Buzza","year":"2001","journal-title":"Kidney Int."},{"key":"10.1016\/j.intimp.2026.117305_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2023.107896","article-title":"The multifaceted roles of COL4A4 in lung adenocarcinoma: an integrated bioinformatics and experimental study","volume":"170","author":"Zheng","year":"2024","journal-title":"Comput. Biol. Med."},{"issue":"2","key":"10.1016\/j.intimp.2026.117305_bb0130","first-page":"196","article-title":"Integrated bioinformatic analysis identifies COL4A3, COL4A4, and KCNJ1 as key biomarkers in Wilms tumor","volume":"14","author":"Guo","year":"2021","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.intimp.2026.117305_bb0135","article-title":"A ceRNA network composed of survival-related lncRNAs, miRNAs, and mRNAs in clear cell renal carcinoma","volume":"2022","author":"Lu","year":"2022","journal-title":"Comput. Math. Methods Med."},{"key":"10.1016\/j.intimp.2026.117305_bb0140","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.994208","article-title":"A newly defined basement membrane-related gene signature for the prognosis of clear-cell renal cell carcinoma","volume":"13","author":"Zhou","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.intimp.2026.117305_bb0145","article-title":"KDF1, a novel tumor suppressor in clear cell renal cell carcinoma","volume":"11","author":"Zheng","year":"2021","journal-title":"Front. Oncol."},{"issue":"12","key":"10.1016\/j.intimp.2026.117305_bb0150","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.ccell.2022.11.001","article-title":"Mapping single-cell transcriptomes in the intra-tumoral and associated territories of kidney cancer","volume":"40","author":"Li","year":"2022","journal-title":"Cancer Cell"},{"issue":"24","key":"10.1016\/j.intimp.2026.117305_bb0155","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2103240118","article-title":"Single-cell analyses of renal cell cancers reveal insights into tumor microenvironment, cell of origin, and therapy response","volume":"118","author":"Zhang","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2026.117305_bb0160","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev-pathol-020117-043854","article-title":"Epithelial mesenchymal transition in tumor metastasis","volume":"13","author":"Mittal","year":"2018","journal-title":"Annu. Rev. Pathol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117305_bb0165","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23010146","article-title":"Matrix metalloproteinases shape the tumor microenvironment in cancer progression","volume":"23","author":"Niland","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2026.117305_bb0170","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1681\/ASN.2021111447","article-title":"Genetic variants of the COL4A3, COL4A4, and COL4A5 genes contribute to thinned glomerular basement membrane lesions in sporadic IgA nephropathy patients","volume":"34","author":"Yuan","year":"2023","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.intimp.2026.117305_bb0175","first-page":"311","article-title":"Basement membrane and the invasive activity of metastatic tumor cells","volume":"77","author":"Terranova","year":"1986","journal-title":"J. Natl. Cancer Inst."},{"issue":"2","key":"10.1016\/j.intimp.2026.117305_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejcb.2022.151220","article-title":"Multiple roles for basement membrane proteins in cancer progression and EMT","volume":"101","author":"Banerjee","year":"2022","journal-title":"Eur. J. Cell Biol."},{"issue":"2","key":"10.1016\/j.intimp.2026.117305_bb0185","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s12032-022-01943-1","article-title":"DNA methylation and cancer: transcriptional regulation, prognostic, and therapeutic perspective","volume":"40","author":"Bhootra","year":"2023","journal-title":"Med. Oncol."},{"issue":"2","key":"10.1016\/j.intimp.2026.117305_bb0190","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s12013-013-9555-2","article-title":"DNA methylation and cancer development: molecular mechanism","volume":"67","author":"Akhavan-Niaki","year":"2013","journal-title":"Cell Biochem. Biophys."},{"issue":"7265","key":"10.1016\/j.intimp.2026.117305_bb0195","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/nature08448","article-title":"JAK2 phosphorylates histone H3Y41 and excludes HP1alpha from chromatin","volume":"461","author":"Dawson","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2026.117305_bb0200","first-page":"395","article-title":"BART is essential for nuclear retention of STAT3","volume":"3","author":"Ryuta","year":"2008","journal-title":"Int. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117305_bb0205","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12943-021-01316-8","article-title":"The cancer metabolic reprogramming and immune response","volume":"20","author":"Xia","year":"2021","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2026.117305_bb0210","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12943-021-01428-1","article-title":"Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives","volume":"20","author":"Mao","year":"2021","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2026.117305_bb0215","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.smim.2014.01.001","article-title":"IL-6 and related cytokines as the critical lynchpins between inflammation and cancer","volume":"26","author":"Taniguchi","year":"2014","journal-title":"Semin. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2026.117305_bb0220","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1172\/JCI73531","article-title":"IL-6R\/STAT3\/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis","volume":"124","author":"Rokavec","year":"2014","journal-title":"J. Clin. Invest."},{"issue":"26","key":"10.1016\/j.intimp.2026.117305_bb0225","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1038\/onc.2016.525","article-title":"CGI-99 promotes breast cancer metastasis via autocrine interleukin-6 signaling","volume":"36","author":"Lin","year":"2017","journal-title":"Oncogene"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926011525?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926011525?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T15:42:48Z","timestamp":1790437368000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926011525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":45,"alternative-id":["S1567576926011525"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117305","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epigenetic inactivation of COL4A4 orchestrates JAK2\/STAT3-driven progression and microenvironment reprogramming in renal cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117305","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117305"}}